Characterising the castration‐resistant prostate cancer population: a systematic review
作者： M. Kirby , C. Hirst , E. D. Crawford
DOI: 10.1111/J.1742-1241.2011.02799.X
关键词:
摘要: … % (25), those with advanced prostate cancer at the time of diagnosis have a median survival of 24.5 months (26). In the CRPC populations included in this review, the median survival …
researchgate.net 
sci-hub.se 参考文章(26)
Mette Nørgaard, Annette Østergaard Jensen, Jacob Bonde Jacobsen, Kara Cetin, Jon P. Fryzek, Henrik Toft Sørensen, Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007) The Journal of Urology. ,vol. 184, pp. 162- 167 ,(2010) , 10.1016/J.JURO.2010.03.034
Fernando J. Bianco, David P. Wood, Michael L. Cher, Isaac J. Powell, Julia W. Souza, J. Edson Pontes, Ten-Year Survival After Radical Prostatectomy: Specimen Gleason Score Is the Predictor in Organ-Confined Prostate Cancer Clinical Prostate Cancer. ,vol. 1, pp. 242- 247 ,(2003) , 10.3816/CGC.2003.N.006
HARRY W. DANIELL, STEPHEN R. DUNN, DAVID W. FERGUSON, GREGORY LOMAS, ZIAD NIAZI, P. TRYG STRATTE, PROGRESSIVE OSTEOPOROSIS DURING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER The Journal of Urology. ,vol. 163, pp. 181- 186 ,(2000) , 10.1016/S0022-5347(05)68000-7
John Wei, Katherine Gravlin, Kathleen A. Cooney, RE: OSTEOPOROSIS AFTER ORCHIECTOMY FOR PROSTATE CANCER The Journal of Urology. ,vol. 158, pp. 439- 444 ,(1997) , 10.1016/S0022-5347(01)62422-4
Ikuko Kato, Richard K. Severson, Ann G. Schwartz, Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data. Cancer. ,vol. 92, pp. 2211- 2219 ,(2001) , 10.1002/1097-0142(20011015)92:8<2211::AID-CNCR1565>3.0.CO;2-W
A Berruti, M Tucci, A Mosca, R Tarabuzzi, G Gorzegno, C Terrone, F Vana, G Lamanna, M Tampellini, F Porpiglia, A Angeli, R M Scarpa, L Dogliotti, Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease. British Journal of Cancer. ,vol. 93, pp. 633- 638 ,(2005) , 10.1038/SJ.BJC.6602767
Alfredo Berruti, Alessandra Mosca, Francesco Porpiglia, Enrico Bollito, Marcello Tucci, Federica Vana, Cecilia Cracco, Mirella Torta, Lucianna Russo, Susanna Cappia, Andrea Saini, Alberto Angeli, Mauro Papotti, Roberto Mario Scarpa, Luigi Dogliotti, Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease. The Journal of Urology. ,vol. 178, pp. 838- 843 ,(2007) , 10.1016/J.JURO.2007.05.018
J. Ferlay, D.M. Parkin, E. Steliarova-Foucher, Estimates of cancer incidence and mortality in Europe in 2008. European Journal of Cancer. ,vol. 46, pp. 765- 781 ,(2010) , 10.1016/J.EJCA.2009.12.014
Vidija Soerdjbalie-Maikoe, Rob C. M. Pelger, Guus A. B. Lycklama à Nijeholt, Jan-Willem Arndt, Aeilko H. Zwinderman, Herman Bril, Socrates E. Papapoulos, Neveen A. T. Hamdy, Bone scintigraphy predicts the risk of spinal cord compression in hormone-refractory prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 31, pp. 958- 963 ,(2004) , 10.1007/S00259-004-1479-Z
Emmanuel S. Antonarakis, Mario A. Eisenberger, Expanding Treatment Options for Metastatic Prostate Cancer New England Journal of Medicine. ,vol. 364, pp. 2055- 2058 ,(2011) , 10.1056/NEJME1102758